Semaglutide can stimulate insulin release when blood glucose is elevated and reduce inappropriate glucagon release
GHK-Cu demonstrates superior effects for skin, surface wounds, and hair while also providing systemic gene expression benefits
Ferrulli and colleagues ran a randomized, sham-controlled trial of 33 adults with obesity: deep TMS targeting the PFC and insula for five weeks produced significant weight loss that persisted at 12-month follow-up [16]
Most patients find that side effects diminish substantially by week 8-12 on a stable dose
Instead, work with your healthcare team to identify the underlying causewhether it's dehydration, rapid weight loss, blood pressure changes, or an unrelated condition
Effect of leptin therapy on survival in generalized and partial lipodystrophy: A matched cohort analysis